Malondialdehyde and coenzyme Q10 in platelets and serum in type 2 diabetes mellitus: Correlation with glycemic control

Blood Coagulation and Fibrinolysis

Volumn 20, Issue 4, 2009, Pages 248-251

  Ei ghoroury, Eman A ^a   Raslan, Hala M ^a   Badawy, Ehsan A ^a   El Saaid, Gamila S ^a   Agybi, Mervat H ^a   Siam, Ibrahem ^a   Salem, Sohair I ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Coenzyme Q10; Diabetes mellitus; Malondialdehyde; Platelets

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; MALONALDEHYDE; UBIDECARENONE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; THROMBOCYTE;

ANTIOXIDANTS; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; RISK FACTORS; UBIQUINONE;

EID: 67649534542     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3283254549     Document Type: Article

References (20)

1. Véricel P, Januel C, Carreras M, Moulin P, Lagarde M. Diabetic patients without vascular complications display enhanced basal platelet activation and decreased antioxidant status. Diabete. 2004; 53:1046-1051.
2. Kaneto H, Xu G, Fuji N, Kim S, Bonner-Weir S, Weir GC. Involvement of C-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression. J Biol Che. 2002; 277:30010-30018.
3. Modi KP, Vishwakarma SL, Goyal R, Bhatt PA. Effects of coenzyme Q10 on lipid levels and antioxidant defences in rats with fructose induced hyperlipidemia and hyperinsulinaemia. Internet J Pharmaco. 2007; 5:1.
4. Sobol AB, Watala C. The role of platelets in diabetes-related vascular complications. Diabetes Res Clin Prac. 2000; 50:1 -16.
5. Calzada C, Véricel E, Mitel B, Coulon L, Lagarde M. 12(S)-hydroxyperoxy- eicosatetraenoic increases arachidonic acid availability in collagen-primed platelets. J Lipid Re. 2001; 42:1467-1473.
6. Mosca F, Fattorini D, Bompadre S, Littarru GP. Assay of coenzyme Q10 in plasma by a single dilution step. Anal Bioche. 2002; 305:49-54.
7. Ashour MN, Heikal OA, Salama EEE. Level of total, reduced, oxidized coenzymeQ.10 and alpha-tocopherol (vitamin E) in plasma of type 1 diabetic children. Kasr El-Aini Med. 2003; 9:21 -31.
8. Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Act. 1978; 90:37-43.
9. Saladi S,Zucchini S, Elleri D, Grossi G, Bargossi A, Gualandi S, era/. High glucose levels induce an increase in membrane antioxidants,in terms of vitamin E and coenzyme Q 10 in children and adolescents with type 1 diabetes. Diabetes Car. 2004; 27:630-631.
10. Hunt JV, Smith C, Wolff SP. Autooxidative glycosylation and possible involvement of peroxides and free radicals an LDL modification by glucose. Diabete. 1990; 39:1420-1424.
11. Cetinkaya A, Kurutas EB, Buyukbese MA, Kantarceken B, Bulbuloglu E. Levels of malondialdehyde and superoxide dismutase in subclinical hyperthyroidism. Mediators Inflam. 2005; 1:57-59.
12. Ozdemir G, Ozden M, Maral H, Kuskav S, Cetinalp P, Tarkun I. Malondialdehyde, glutathione, glutathione peroxidaseand homocysteine levels in type 2 diabetic patients with and without microalbuminuria. Ann Clin Bioche. 2005; 42:99-104.
13. Wen YR, Chang LP, Chen HL, Liu CF. Comparison of interlukin-6 and malondialdehyde levels in diabetic patients in Taiwan. Diabetes Nutr Meta. 2004; 17:368-370.
14. Özben T, Nacitarhan S, Tuncer N. Plasma and urine malondialdehyde levels in noninsulin-dependent diabetic patients with and without microalbuminuria. Int J Clin Lab Re. 1995; 25:162-164.
15. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Natur. 2001; 414:813-820.
16. Constantinescu R, McDermott MP, DiCenzo R, de Blieck E, Hyson C, Beal F, et al. A randomized study of the bioavailability of different formulations of coenzyme Q,0 (Ubiquinone). J Clin Pharmaco. 2007; 47:1580-1586.
17. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabete. 2005; 54:1615-1625.
18. Chew GT, Watts GF. Coenzyme Q10 and diabetic endotheliopathy: oxidative stree and the 'recoupling hypothesis'. Q J Me. 2004; 97:537- 548.
19. Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. J Hum Hyperten. 1999; 13:203-208.
20. Hodgson JM, Watts GF, Playford DA, Burke V, Croft KD. Coenzyme Q10 improves blood pressure and glycemic control: a controlled trial in subjects with type 2 diabetes. Eur J Clin Nut. 2001; 56:1137-1142.